Bageo Pharmaceuticals Private Limited

Bageo Pharmaceuticals Private Limited - business services in Salem, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U74999TZ2019PTC031589 Incorporated 24 January 2019 ROC Coimbatore HQ Salem, Tamil Nadu, India
Active Private Limited Company business services MSME · Micro
Data last updated
Revenue · FY 2022
₹1.24 Cr
▲ 45% YoY
Net profit · FY 2022
₹4.44 Lakh
Net margin 3.6%
EBITDA · FY 2022
₹11.01 Lakh
EBITDA margin 8.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered

About Bageo Pharmaceuticals Private Limited

Data last updated:

Bageo Pharmaceuticals Private Limited is a private limited company based in Salem, Tamil Nadu, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 24 January 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U74999TZ2019PTC031589. Its GSTIN is 33AAICB2405M1ZU (Tamil Nadu).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Chandran Sathishkumar and Suriyan Chandrasekar.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Shop No: 6/10 Senthil Complex Chinnathiruppathy Salem – 636008, Tamil Nadu, India – 636008.

As per the financials filed for FY 2022, the company reported a revenue of ₹1.24 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹4.44 Lakh (net margin 3.6%) and EBITDA of ₹11.01 Lakh (EBITDA margin 8.9%).

Bageo Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-20-0046506). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999TZ2019PTC031589
Registration Number 031589
Incorporation Date 24 January 2019
ROC Coimbatore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-20-0046506

Recognitions & Rankings of Bageo Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TN-20-0046506

Contact details

Bageo Pharmaceuticals Private Limited's registered office is in Salem, Tamil Nadu. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Shop No: 6/10 Senthil Complex Chinnathiruppathy Salem – 636008, Tamil Nadu, India – 636008
  • Industry
    Business Services, Miscellaneous Business Activities, Other Services

To see the full contact details of Bageo Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Bageo Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Bageo Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Bageo Pharmaceuticals Private Limited, buy the company report.

Financials of Bageo Pharmaceuticals Private Limited

FY 2022 filings available

Bageo Pharmaceuticals Private Limited reported revenue of ₹1.24 Cr (up 45% YoY) for FY 2022.

Revenue · FY 2022
₹1.24 Cr ▲ 45%
Net profit · FY 2022
₹4.44 Lakh margin 3.6%
EBITDA · FY 2022
₹11.01 Lakh margin 8.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 45%
EBITDA CAGR growth
1 year
▲ 113%

Revenue rose 45% in the latest year. EBITDA rose 113% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹11.01 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4.44 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin8.9%
Net Profit Margin3.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Bageo Pharmaceuticals Private Limited, buy the company report.

Board of directors of Bageo Pharmaceuticals Private Limited

Bageo Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Chandran SathishkumarDirector30 Nov 20214 Years 11 MonthsCurrent
Suriyan ChandrasekarDirector24 Jan 20197 Years 9 MonthsCurrent
Mohammed Abdul Salam Mohamed Abdul RahimDirector24 Jan 20197 Years 9 MonthsCurrent
Balachandar ChinnasamyDirector24 Jan 20197 Years 9 MonthsCurrent

Peer comparison

Bageo Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Zoydec Pharmaceuticals Private Limited₹1.25 Cr (FY 2025)19.0%Chandigarh, India
Revanex Pharmaceuticals Private Limited₹1.25 Cr (FY 2025)187.0%Siliguri, West Bengal, India
Bageo Pharmaceuticals Private Limitedthis company₹1.24 Cr (FY 2022)₹4.44 Lakh3.6%45.0%Salem, Tamil Nadu, India
Arushnova Pharmaceuticals Private Limited₹1.24 Cr (FY 2025)37.0%Lucknow, Uttar Pradesh, India
Greatlee Pharmaceuticals Private Limited₹1.24 Cr (FY 2025)7.0%Sanand, Gujarat, India

To see the full peer comparison of Bageo Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bageo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Bageo Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAICB2405M1ZUTamil NaduActive28 Feb 2019

To see the full GST registrations and return filing status of Bageo Pharmaceuticals Private Limited, buy the company report.

Recent activity

Bageo Pharmaceuticals Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Gunabalan Senthil Kumar ceased to be Director on 28 Nov 2022.

Ceased
Gunabalan Senthil Kumar ceased to be Director.
AGM
Bageo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Bageo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Coimbatore.
Appointed
Chandran Sathishkumar was appointed as Director.
Appointed
Balachandar Chinnasamy was appointed as Director.
Appointed
Mohammed Abdul Salam Mohamed Abdul Rahim was appointed as Director.
Appointed
Suriyan Chandrasekar was appointed as Director.
Incorporation
24 Jan 2019
Bageo Pharmaceuticals Private Limited was registered on 24 Jan 2019 with Roc Coimbatore & aged 7 years 9 months as per MCA records.

Frequently asked questions

Bageo Pharmaceuticals is an active private limited company based in Salem, Tamil Nadu, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 24 January 2019 (7+ years old) and is registered under CIN U74999TZ2019PTC031589.

Bageo Pharmaceuticals has 4 current directors:

The latest financial statements of Bageo Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Bageo Pharmaceuticals is 33AAICB2405M1ZU, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Bageo Pharmaceuticals is U74999TZ2019PTC031589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bageo Pharmaceuticals was incorporated on 24 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Coimbatore.

The peers of Bageo Pharmaceuticals by revenue are Zoydec Pharmaceuticals Private Limited, Revanex Pharmaceuticals Private Limited, Arushnova Pharmaceuticals Private Limited, Greatlee Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Gunabalan Senthil Kumar ceased to be Director on 28 Nov 2022. Chandran Sathishkumar was appointed as Director on 30 Nov 2021. Balachandar Chinnasamy was appointed as Director on 24 Jan 2019. Bageo Pharmaceuticals has 5 board changes on record in total.

Yes, Bageo Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-20-0046506).

The registered office of Bageo Pharmaceuticals is at Shop No: 610 Senthil Complex Chinnathiruppathy Salem – 636008, Tamil Nadu, India – 636008.

Bageo Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.